115 related articles for article (PubMed ID: 35950938)
1. Trends in diabetes incidence and associated risk factors among people with HIV in the current treatment era.
Spieler G; Westfall AO; Long DM; Cherrington A; Burkholder GA; Funderburg N; Raper JL; Overton ET; Willig AL
AIDS; 2022 Nov; 36(13):1811-1818. PubMed ID: 35950938
[TBL] [Abstract][Full Text] [Related]
2. Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015.
Sun J; Althoff KN; Jing Y; Horberg MA; Buchacz K; Gill MJ; Justice AC; Rabkin CS; Goedert JJ; Sigel K; Cachay E; Park L; Lim JK; Kim HN; Lo Re V; Moore R; Sterling T; Peters MG; Achenbach CJ; Silverberg M; Thorne JE; Mayor AM; Crane HM; Kitahata MM; Klein M; Kirk GD;
JAMA Netw Open; 2021 Feb; 4(2):e2037512. PubMed ID: 33595662
[TBL] [Abstract][Full Text] [Related]
3. Incidence of diabetes mellitus in a population-based cohort of HIV-infected and non-HIV-infected persons: the impact of clinical and therapeutic factors over time.
Tripathi A; Liese AD; Jerrell JM; Zhang J; Rizvi AA; Albrecht H; Duffus WA
Diabet Med; 2014 Oct; 31(10):1185-93. PubMed ID: 24673640
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic Fatty Liver Disease and the Development of Metabolic Comorbid Conditions in Patients With Human Immunodeficiency Virus Infection.
Krahn T; Martel M; Sapir-Pichhadze R; Kronfli N; Falutz J; Guaraldi G; Lebouche B; Klein MB; Wong P; Deschenes M; Ghali P; Sebastiani G
J Infect Dis; 2020 Aug; 222(5):787-797. PubMed ID: 32249283
[TBL] [Abstract][Full Text] [Related]
5. Association of HIV infection with incident diabetes mellitus: impact of using hemoglobin A1C as a criterion for diabetes.
Tien PC; Schneider MF; Cox C; Karim R; Cohen M; Sharma A; Young M; Glesby MJ
J Acquir Immune Defic Syndr; 2012 Nov; 61(3):334-40. PubMed ID: 22878421
[TBL] [Abstract][Full Text] [Related]
6. Individual-Level and Clinic-Level Factors Associated With Achieving Glycemic Control in a Large Cohort of People With HIV in Care-Washington, DC.
Happ LP; Monroe AK; Young HA; Ma Y; Greenberg AE; Horberg MA; Castel AD;
J Acquir Immune Defic Syndr; 2020 Sep; 85(1):113-122. PubMed ID: 32541383
[TBL] [Abstract][Full Text] [Related]
7. Diabetes mellitus burden among people living with HIV from the Asia-Pacific region.
Han WM; Jiamsakul A; Kiertiburanakul S; Ng OT; Sim BL; Sun LP; Van Nguyen K; Choi JY; Lee MP; Wong WW; Kamarulzaman A; Kumarasamy N; Zhang F; Tanuma J; Do CD; Chaiwarith R; Merati TP; Yunihastuti E; Pujari S; Ditangco R; Khusuwan S; Ross J; Avihingsanon A;
J Int AIDS Soc; 2019 Jan; 22(1):e25236. PubMed ID: 30697944
[TBL] [Abstract][Full Text] [Related]
8. Incident Proteinuria differs by HIV Serostatus among Men with Pre-diabetes: The Multicenter AIDS Cohort Study.
Slama L; Barrett BW; Abraham AG; Palella FJ; Magnani JW; Viard JP; Lake JE; Brown TT
Clin Infect Dis; 2024 Feb; ():. PubMed ID: 38335094
[TBL] [Abstract][Full Text] [Related]
9. African Mitochondrial DNA Haplogroup L2 Is Associated With Slower Decline of β-cell Function and Lower Incidence of Diabetes Mellitus in Non-Hispanic, Black Women Living With Human Immunodeficiency Virus.
Sun J; Brown TT; Tong W; Samuels D; Tien P; Aissani B; Aouizerat B; Villacres M; Kuniholm MH; Gustafson D; Michel K; Cohen M; Schneider M; Adimora AA; Ali MK; Bolivar H; Hulgan T
Clin Infect Dis; 2020 Nov; 71(8):e218-e225. PubMed ID: 31927570
[TBL] [Abstract][Full Text] [Related]
10. Incident diabetes in course of antiretroviral therapy.
Taramasso L; Squillace N; Ricci E; Menzaghi B; Orofino G; Socio GV; Molteni C; Martinelli CV; Madeddu G; Vichi F; Valsecchi L; Celesia BM; Maggi P; Rusconi S; Pellicanò GF; Cascio A; Sarchi E; Gulminetti R; Falasca K; Di Biagio A; Bonfanti P;
AIDS; 2023 Jul; 37(8):1269-1276. PubMed ID: 36927963
[TBL] [Abstract][Full Text] [Related]
11. Determinants of incident chronic kidney disease and progression in a cohort of HIV-infected persons with unrestricted access to health care.
Ganesan A; Krantz EM; Huppler Hullsiek K; Riddle MS; Weintrob AC; Lalani T; Okulicz JF; Landrum M; Agan B; Whitman TJ; Ross MJ; Crum-Cianflone NF;
HIV Med; 2013 Feb; 14(2):65-76. PubMed ID: 22808988
[TBL] [Abstract][Full Text] [Related]
12. New-onset diabetes in HIV-treated adults: predictors, long-term renal and cardiovascular outcomes.
Putcharoen O; Wattanachanya L; Sophonphan J; Siwamogsatham S; Sapsirisavat V; Gatechompol S; Phonphithak S; Kerr SJ; Chattranukulchai P; Avihingsanon Y; Ruxrungtham K; Avihingsanon A;
AIDS; 2017 Jul; 31(11):1535-1543. PubMed ID: 28398958
[TBL] [Abstract][Full Text] [Related]
13. The incidence of and risk factors for hospitalized acute kidney injury among people living with HIV on antiretroviral treatment.
Muiru AN; Madden E; Chilingirian A; Rubinsky AD; Scherzer R; Moore R; Villalobos CPC; Monroy Trujillo JM; Parikh CR; Hsu CY; Shlipak MG; Estrella MM
HIV Med; 2022 Jul; 23(6):611-619. PubMed ID: 34897925
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study.
Ledergerber B; Furrer H; Rickenbach M; Lehmann R; Elzi L; Hirschel B; Cavassini M; Bernasconi E; Schmid P; Egger M; Weber R;
Clin Infect Dis; 2007 Jul; 45(1):111-9. PubMed ID: 17554711
[TBL] [Abstract][Full Text] [Related]
15. Risk for incident diabetes is greater in prediabetic men with HIV than without HIV.
Slama L; Barrett BW; Abraham AG; Palella FJ; Kingsley L; Viard JP; Lake JE; Brown TT;
AIDS; 2021 Aug; 35(10):1605-1614. PubMed ID: 33859110
[TBL] [Abstract][Full Text] [Related]
16. Effect of the introduction of screening for cancer precursor lesions on anal cancer incidence over time in people living with HIV: a nationwide cohort study.
van der Zee RP; Wit FWNM; Richel O; van der Valk M; Reiss P; de Vries HJC; Prins JM;
Lancet HIV; 2023 Feb; 10(2):e97-e106. PubMed ID: 36640800
[TBL] [Abstract][Full Text] [Related]
17. Incidence of cardiometabolic outcomes among people living with HIV-1 initiated on integrase strand transfer inhibitor versus non-integrase strand transfer inhibitor antiretroviral therapies: a retrospective analysis of insurance claims in the United States.
Rebeiro PF; Emond B; Rossi C; Bookhart BK; Shah A; Caron-Lapointe G; Lafeuille MH; Donga P
J Int AIDS Soc; 2023 Jun; 26(6):e26123. PubMed ID: 37306118
[TBL] [Abstract][Full Text] [Related]
18. Fracture Risk and Association With TDF Use Among People With HIV in Large Integrated Health Systems.
Hechter RC; Zhou H; Leyden WA; Yuan Q; Pak KJ; Lam JO; Alexeeff S; Lea A; Hu H; Marcus JL; Rivera AS; Adams AL; Horberg MA; Towner WJ; Lo JC; Silverberg MJ
J Acquir Immune Defic Syndr; 2023 Dec; 94(4):341-348. PubMed ID: 37884055
[TBL] [Abstract][Full Text] [Related]
19. Synergy between low BMI and hyperglycemia at baseline increases tuberculosis incidence among people living with HIV.
Kyaw NTT; Kumar AMV; Harries AD; Satyanarayana S; Oo NL; Hayat MJ; Castro KG; Magee MJ
AIDS; 2022 Jan; 36(1):117-125. PubMed ID: 34586087
[TBL] [Abstract][Full Text] [Related]
20. Association of glucose-lowering drugs with incident stroke and transient ischaemic attacks in primary care patients with type 2 diabetes: disease analyzer database.
Rathmann W; Kostev K
Acta Diabetol; 2022 Nov; 59(11):1443-1451. PubMed ID: 35933524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
